Commonwealth Equity Services’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $818K | Sell |
|
|||||
|
2025
Q1 | $1.01M | Buy |
|
|||||
|
2024
Q4 | $821K | Buy |
|
|||||
|
2024
Q3 | $335K | Sell |
|
|||||
|
2024
Q2 | $293K | Sell |
|
|||||
|
2024
Q1 | $312K | Sell |
|
|||||
|
2023
Q4 | $340K | Buy |
|
|||||
|
2023
Q3 | $201K | Sell |
|
|||||
|
2023
Q2 | $323K | Buy |
|
|||||
|
2023
Q1 | $342 | Buy |
|
|||||
|
2022
Q4 | $376K | Buy |
|
|||||
|
2022
Q3 | $204K | Buy |
|
|||||
|
2022
Q2 | $95K | Buy |
|
|||||
|
2022
Q1 | $89K | Sell |
|
|||||
|
2021
Q4 | $87K | Buy |
|
|||||
|
2021
Q3 | $64K | Buy |
|
|||||
|
2021
Q2 | $63K | Hold |
|
|||||
|
2021
Q1 | $50K | Sell |
|
|||||
|
2020
Q4 | $41K | Sell |
|
|||||
|
2020
Q3 | $39K | Hold |
|
|||||
|
2020
Q2 | $61K | Sell |
|
|||||
|
2020
Q1 | $62K | Hold |
|
|||||
|
2019
Q4 | $61K | Hold |
|
|||||
|
2019
Q3 | $86K | Sell |
|
|||||
|
2019
Q2 | $66K | Sell |
|
|||||
|
2019
Q1 | $146K | Buy |
|
|||||
|
2018
Q4 | $53K | Buy |
|
|||||
|
2018
Q3 | $91K | Sell |
|
|||||
|
2018
Q2 | $77K | Hold |
|
|||||
|
2018
Q1 | $59K | Hold |
|
|||||
|
2017
Q4 | $97K | Buy |
|
|||||
|
2017
Q3 | $60K | Hold |
|
|||||
|
2017
Q2 | $66K | Sell |
|
|||||
|
2017
Q1 | $47K | Buy |
|
|||||
|
2016
Q4 | $25K | Hold |
|
|||||
|
2016
Q3 | $26K | Sell |
|
|||||
|
2016
Q2 | $18K | Sell |
|
|||||
|
2016
Q1 | $35K | Hold |
|
|||||
|
2015
Q4 | $72K | Buy |
|
|||||
|
2015
Q3 | $86K | Sell |
|
|||||
|
2015
Q2 | $145K | Buy |
|
|||||
|
2015
Q1 | $48K | Buy |
|